The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Basic local alignment search tool

Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

Wiedenmann, B. J., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,432

Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation

Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361

Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases

Kennelly, P. J., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98436-x · Cited by 1,331

NMR Structure of Calmodulin Complexed to an N-Terminally Acetylated α-Synuclein Peptide

Gruschus, J. M., Yap, T. L., Pistolesi, S., Maltsev, A. S., & Lee, J. C. (2013) · Biochemistry · doi:10.1021/bi400199p · Cited by 28

Synucleinopathies: a pathological and molecular review

Murray, I. V. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00023-8 · Cited by 28

The effects of α-synuclein on phospholipid vesicle integrity: a study using31P NMR and electron microscopy

Madine, J., Hughes, E., Doig, A. J., & Middleton, D. A. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802467977 · Cited by 28

Subcellular orchestration of alpha-synuclein variants in Parkinson’s disease brains revealed by 3D multicolor STED microscopyPreprint

Moors, T. E., Maat, C. A., Niedieker, D., Mona, D., Petersen, D., Huisman, E., Kole, J., El-Mashtoly, S. F., Spycher, L., Zago, W., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/470476 · Cited by 28

Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson’s Disease

Stanojlović, M., Pallais, J. P., & Kotz, C. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00702 · Cited by 27

Propofol Attenuates α-Synuclein Aggregation and Neuronal Damage in a Mouse Model of Ischemic Stroke

Wang, Y., Tian, D., Wei, C., Cui, V., Wang, H., Zhu, Y., Wu, A., & Yue, Y. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00426-0 · Cited by 27

Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far

Sivagurunathan, N., Gnanasekaran, P., & Latchoumycandane, C. (2023) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s361526 · Cited by 29

Update on Dementia with Lewy Bodies

Karantzoulis, S., & Galvin, J. E. (2013) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-013-0053-6 · Cited by 27

Copper(I) Forms a Redox-Stable 1:2 Complex with α-Synuclein N-Terminal Peptide in a Membrane-Like Environment

Dell’Acqua, S., Pirota, V., Monzani, E., Camponeschi, F., Ricco, R. D., Valensin, D., & Casella, L. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.6b00641 · Cited by 27

In‐Cell NMR Spectroscopy of Intrinsically Disordered Proteins

Sciolino, N., Burz, D. S., & Shekhtman, A. G. (2018) · PROTEOMICS · doi:10.1002/pmic.201800055 · Cited by 27

Expression of α-synuclein in the human brain: relation to Lewy body disease

Wirdefeldt, K., Bogdanović, N., Westerberg, L. S., Payami, H., Schalling, M., & MURDOCH, G. H. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00150-4 · Cited by 27

Genetic influence on the development of Parkinson’s disease

Rieß, O., Kuhn, W., & Krüger, R. (2000) · Journal of Neurology · doi:10.1007/pl00007764 · Cited by 27

Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus

Mori, F., Hayashi, S., Yamagishi, S., Yoshimoto, M., Yagihashi, S., Takahashi, H., & Wakabayashi, K. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0578-9 · Cited by 27

Can Intrabodies Serve as Neuroprotective Therapies for Parkinson's Disease? Beginning Thoughts

Bhatt, M. A., Messer, A. C., & Kordower, J. H. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130252 · Cited by 26

A Four-Amino Acid Linker between Repeats in the α-Synuclein Sequence Is Important for Fibril Formation

Shvadchak, V. V., & Subramaniam, V. (2014) · Biochemistry · doi:10.1021/bi401427t · Cited by 26

Revista Española de Geriatría y Gerontología

Santos, R. P., Torres, C. F., Martín‐Arranz, M. D., de Parga, J. M. S., & Martínez, M. A. (2016) · Cited by 26

Purification of α-synuclein containing inclusions from human post mortem brain tissue

McCormack, A., Chegeni, N., Chegini, F., Colella, A. D., Power, J., Keating, D. J., & Chataway, T. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.03.016 · Cited by 26

Mapping of Rat Brain Using the Synuclein-1 Monoclonal Antibody Reveals Somatodendritic Expression of α-Synuclein in Populations of Neurons Homologous to those Vulnerable to Lewy Body Formation in Human Synucleopathies

Andringa, G., Du, F., Chase, T. N., & Bennett, M. C. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.10.1060 · Cited by 26

Expression of β-synuclein in normal human astrocytes

Tanji, K., Mori, F., Nakajo, S., Imaizumi, T., Yoshida, H., Hirabayashi, T., Yoshimoto, M., Satoh, K., Takahashi, H., & Wakabayashi, K. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00018 · Cited by 26

Antiparkinsonian Drugs and Their Neuroprotective Effects.

Kitamura, Y., Kakimura, J., & Taniguchi, T. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.284 · Cited by 26

Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations

Palomo, T., Beninger, R. J., Kostrzewa, R. M., & Archer, T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033369 · Cited by 26

Neuronal constitutive endolysosomal perforations enable α-synuclein aggregation by internalized PFFs

Sanyal, A., Scanavachi, G., Somerville, E., Saminathan, A., Nair, A., Correia, R. F. B. D. C., Aylan, B., Sitarska, E., Oikonomou, A., Hatzakis, N. S., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202401136 · Cited by 26

G6PD deficiency triggers dopamine loss and the initiation of Parkinson’s disease pathogenesis

Stykel, M. G., Siripala, S. V., Soubeyrand, E., Coackley, C. L., Lu, P., Camargo, S., Thevasenan, S., Figueroa, G. B., So, R. W. L., Stuart, E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115178 · Cited by 25

Stimulation of α-synuclein amyloid formation by phosphatidylglycerol micellar tubules

Jiang, Z., Flynn, J. D., Teague, W. E., Gawrisch, K., & Lee, J. C. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.025 · Cited by 25

Finding Order within Disorder: Elucidating the Structure of Proteins Associated with Neurodegenerative Disease

Huang, A., & Stultz, C. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.40 · Cited by 26

Residue Glu83 plays a major role in negatively regulating α-synuclein amyloid formation

Waxman, E. A., Emmer, K. L., & Giasson, B. I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.079 · Cited by 23

Interactions between the amyloid precursor protein C‐terminal domain and G proteins mediate calcium dysregulation and amyloid β toxicity in Alzheimer’s disease

Shaked, G. M., Chauv, S., Ubhi, K. K., Hansen, L. A., & Masliah, E. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06997.x · Cited by 25

Molecular Understanding of Copper and Iron Interaction with α-Synuclein by Fluorescence Analysis

..., B., & Rao, K. S. J. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9076-4 · Cited by 26

Endogenous Leucine-Rich Repeat Kinase 2 Slows Synaptic Vesicle Recycling in Striatal Neurons

Maas, J. W. J., Yang, J., & Edwards, R. H. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00005 · Cited by 27

Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein

Phelan, M. M., Caamaño‐Gutiérrez, E., Gant, M. S., Grosman, R., & Madine, J. (2017) · Metabolomics · doi:10.1007/s11306-017-1289-5 · Cited by 24

Modulation of Correlated Segment Fluctuations in IDPs upon Complex Formation as an Allosteric Regulatory Mechanism

Beier, A., Schwarz, T. C., Kurzbach, D., Platzer, G., Tribuzio, F., & Konrat, R. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.035 · Cited by 26

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons

Goloborshcheva, V., Kucheryanu, V. G., Voronina, N. A., Teterina, E. V., Ustyugov, A. A., & Morozov, S. (2022) · Biomedicines · doi:10.3390/biomedicines10092278 · Cited by 24

Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations

Patrias, L. M., Klaver, A. C., Coffey, M. P., & Loeffler, D. A. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04214.x · Cited by 24

Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography

Cao, Z., Wu, Y., Liu, G., Jiang, Y., Wang, X., Wang, Z., & Feng, T. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01043 · Cited by 24

Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic mice

Masliah, E., Rockenstein, E. M., Inglis, C. A., Adame, A., Bett, C. K., Lucero, M., & Sigurdson, C. J. (2012) · Prion · doi:10.4161/pri.19806 · Cited by 26

γ-Synuclein Antibodies Have Neuroprotective Potential on Neuroretinal Cells via Proteins of the Mitochondrial Apoptosis Pathway

Wilding, C., Bell, K. C., Gehrke-Beck, S., Funke, S., Pfeiffer, N., & Grus, F. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090737 · Cited by 24

Regulation of alpha‐synuclein expression in alcohol‐preferring and ‐non preferring rats

Liang, T., & Carr, L. G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04111.x · Cited by 24

Novel therapeutic approaches in multiple system atrophy

Palma, J.-A., & Kaufmann, H. (2015) · Clinical Autonomic Research · doi:10.1007/s10286-014-0249-7 · Cited by 24

MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation

Lee, S., Oh, S. T., Jeong, H. J., Pak, S. C., Park, H., Kim, J., Cho, H., & Jeon, S. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.6.625 · Cited by 24

Amyloid Formation of α-Synuclein Based on the Solubility- and Supersaturation-Dependent Mechanism

Sawada, M., Yamaguchi, K., Hirano, M., Noji, M., So, M., Otzen, D. E., Kawata, Y., & Goto, Y. (2020) · Langmuir · doi:10.1021/acs.langmuir.0c00426 · Cited by 26

Functional protein kinase arrays reveal inhibition of p‐21‐activated kinase 4 by α‐synuclein oligomers

Danzer, K. M., Schnack, C., Sutcliffe, A., Hengerer, B., & Gillardon, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04933.x · Cited by 24

A Versatile Method for Site-Specific Chemical Installation of Aromatic Posttranslational Modification Analogs into Proteins

Lin, X., Mandal, S., Nithun, R. V., Rajasekhar, K., Bouri, B., Lashuel, H. A., & Jbara, M. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c08416 · Cited by 22

Vertebrate food products as a potential source of prion-like α-synuclein

Killinger, B. A., & Labrie, V. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0035-z · Cited by 23

Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons

Colla, E., Panattoni, G., Ricci, A., Rizzi, C., Rota, L., Carucci, N. M., Valvano, V., Gobbo, F., Capsoni, S., Lee, M. K., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.004 · Cited by 23

Alpha-Synuclein—Nanoparticle Interactions: Understanding, Controlling and Exploiting Conformational Plasticity

D’Onofrio, M., Munari, F., & Assfalg, M. (2020) · Molecules · doi:10.3390/molecules25235625 · Cited by 23

Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence

Henriques, A., Rouvière, L., Giorla, E., Farrugia, C., Waly, B. E., Poindron, P., & Callizot, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179864 · Cited by 24

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay

Welinder, C., Jönsson, G. B., Ingvar, C., Lundgren, L., Baldetorp, B., Olsson, H. L., Breslin, T., Rezeli, M., Jansson, B., Fehniger, T. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110804 · Cited by 24

NMR Structure of Calmodulin Complexed to an N-Terminally Acetylated α-Synuclein Peptide

Gruschus, J. M., Yap, T. L., & Lee, J. C. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.11.330 · Cited by 23

LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson’s Disease

Hyun, C. H., Yoon, C. Y., Lee, H.-J., & Lee, S. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.249 · Cited by 24

A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies

Ryskalin, L., Busceti, C. L., Limanaqi, F., Biagioni, F., Gambardella, S., & Fornai, F. (2017) · Current Protein and Peptide Science · doi:10.2174/1389203718666171117110028 · Cited by 23

Alpha-synuclein in salivary gland as biomarker for Parkinson’s disease

Campo, F., Carletti, R., Fusconi, M., Pellicano, C., Pontieri, F. E., Gioia, C. R. T. D., & VINCENTIIS, M. D. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0064 · Cited by 24

Genetic Association between Alzheimer Disease and the Alpha-Synuclein Gene

Matsubara, M., Yamagata, H. D., Kamino, K., Nomura, T., Kohara, K., Kondo, I., & Miki, T. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051243 · Cited by 23

Decreases in soluble α-synuclein in frontal cortex correlate with cognitive decline in the elderly

Wang, D.-S., Bennett, D. A., Mufson, E. J., Cochran, E. J., & Dickson, D. W. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.044 · Cited by 23

Reciprocal accumulation of β-synuclein in α-synuclein lesions in multiple system atrophy

Mori, F., Nishie, M., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2003) · Neuroreport · doi:10.1097/00001756-200310060-00005 · Cited by 23

A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease

Uden, E. V., Veinbergs, I., Mallory, M. E., Orlando, R. A., & Masliah, E. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00272-3 · Cited by 23

A Gene for Parkinson Disease

Chase, T. N. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210084017 · Cited by 23

Aspects of innate immunity and Parkinson's disease

Huang, Y., & Halliday, G. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00033 · Cited by 22

Lipid rafts involvement in the pathogenesis of Parkinson s disease

Kubo, S. (2015) · Frontiers in bioscience · doi:10.2741/4308 · Cited by 22

Sensing α‐Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration

Brás, I. C., Lopes, L. V., & Outeiro, T. F. (2018) · Movement Disorders · doi:10.1002/mds.27478 · Cited by 24

CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice

Calò, L., Hidari, E., Węgrzynowicz, M., Dalley, J. W., Schneider, B. L., Podgajna, M., Anichtchik, O. V., Carlson, E., Klenerman, D., & Spillantini, M. G. (2021) · Brain · doi:10.1093/brain/awab076 · Cited by 22

α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword

Tan, L. Y., Tang, K. H., Lim, L. Y. Y., Ong, J. X., Park, H., & Jung, S. (2022) · Biomolecules · doi:10.3390/biom12040507 · Cited by 22

Lysophosphatidylcholine binds α-synuclein and prevents its pathological aggregation

Zhao, C., Tu, J., Wang, C., Liu, W., Gu, J., Yin, Y., Zhang, S., Li, D., Diao, J., Zhu, Z., et al. (2024) · National Science Review · doi:10.1093/nsr/nwae182 · Cited by 23

Ca2+ modulating α-synuclein membrane transient interactions revealed by solution NMR spectroscopy

Zhang, Z., Dai, C., Bai, J. Q. A., Xu, G., Liu, M., & Li, C. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.11.016 · Cited by 22

A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA)

Armstrong, R. A., Cairns, N. J., & Lantos, P. L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0105-8 · Cited by 22

Challenges in studying the structures of metal-amyloid oligomers related to type 2 diabetes, Parkinson's disease, and Alzheimer's disease

Wineman‐Fisher, V., Bloch, D. N., & Miller, Y. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.04.010 · Cited by 22

Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis

Grimm, M. O. W., Lauer, A. A., Grösgen, S., Thiel, A., Lehmann, J., Winkler, J., Janitschke, D., Herr, C., Beißwenger, C., Bals, R., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.015 · Cited by 22

Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration

Yeboah, F., Kim, T., Bill, A., & Dettmer, U. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104543 · Cited by 22

Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors

Satoh, J., & Kuroda, Y. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00075-4 · Cited by 22

Role of Mitochondrial Dysfunction in Parkinson???s Disease

Ramsey, C. P., & Giasson, B. I. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00002 · Cited by 22

Age-dependent differential regulation of genes encoding APP and α-synuclein in hippocampal synaptic plasticity

Stéphan, A., Davis, S., Salin, H., Dumas, S., Mallet, J. J., & Laroche, S. (2002) · Hippocampus · doi:10.1002/hipo.10006 · Cited by 22

Importance of familial Parkinson’s disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson’s disease

Hattori, N., Shimura, H., Kubo, S., Wang, M., Shimizu, N., Tanaka, K., & Mizuno, Y. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_6 · Cited by 22

Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy

Wang, P., & Ye, Y. (2021) · Life · doi:10.3390/life11090938 · Cited by 21

An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation

Cai, Y., Xue, Z.-Q., Zhang, X.-M., Li, M.-R., Wang, H., Luo, X. G., Cai, H., & Yan, X.-X. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.043 · Cited by 21

A variable poly‐T sequence modulates α‐synuclein isoform expression and is associated with aging

Beyer, K., Humbert, J., Ferrer, A. L., Lao, J. I., Latorre, P., López, D., Tolosa, E. S., Ferrer, I., & Ariza, A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21270 · Cited by 22

Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy

Komori, T., Ishizawa, K., Arai, N., Hirose, T., Mizutani, T., & Oda, M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0702-5 · Cited by 21

Parkinson's Disease: Genetics and Pathogenesis

Testa, C. M. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn063 · Cited by 21

L‐DOPA regulates α‐synuclein accumulation in experimental parkinsonism

Deffains, M., Canron, M., Teil, M., Li, Q., Dehay, B., Bézard, E., & Fernagut, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12678 · Cited by 21

Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregation

Chlebowicz, J., Russ, W. P., Chen, D., Vega, A. R., Vernino, S. A., White, C. L., Rizo, J., Joachimiak, Ł. A., & Diamond, M. I. (2023) · Science Advances · doi:10.1126/sciadv.adh3457 · Cited by 19

Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives

Lázaro, D. F., & Lee, V. M. ‐. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.017 · Cited by 20

Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo

Marmolino, D., Foerch, P., Atienzar, F., Staelens, L., Michel, A., & Scheller, D. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.12.012 · Cited by 22

Multiple system atrophy: experimental models and reality

Overk, C., Rockenstein, E. M., Valera, E., Stefanova, N., Wenning, G. K., & Masliah, E. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1772-0 · Cited by 23

Parkinson’s disease: what the model systems have taught us so far

Ghatak, S., Trudler, D., Dolatabadi, N., & Ambasudhan, R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0960-6 · Cited by 20

Amyloid oligomerization of the Parkinson's disease related protein α‐synuclein impacts on its curvature‐membrane sensitivity

Gallea, J. I., Ambroggio, E. E., Vilcaes, A. A., James, N. G., Jameson, D. M., & Celej, M. S. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14573 · Cited by 20

Reciprocal Effects of α-Synuclein Overexpression and Proteasome Inhibition in Neuronal Cells and Tissue

Dyllick‐Brenzinger, M., D’Souza, C. A., Dahlmann, B., Kloetzel, P., & Tandon, A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9094-1 · Cited by 20

Expression of alpha-synuclein in non-apoptotic, slowly degenerating facial motoneurones

Moran, L. B., Kösel, S., Spitzer, C., Schwaiger, F., Rieß, O., Kreutzberg, G. W., & Graeber, M. B. (2001) · Journal of Neurocytology · doi:10.1023/a:1015697318437 · Cited by 20

Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review

Liampas, I., Kyriakoulopoulou, P., Siokas, V., Tsiamaki, E., Stamati, P., Kefalopoulou, Z. M., Chroni, E., & Dardiotis, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031795 · Cited by 30

The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease

Inekci, D., Jonesco, D. S., Kennard, S., Karsdal, M. A., & Henriksen, K. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00090 · Cited by 19

SUMO modulation of protein aggregation and degradation

Feligioni, M., Marcelli, S., Knock, E., Nadeem, U., Arancio, O., & Fraser, P. E. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.4.382 · Cited by 19

The role of α-synuclein in neurodegeneration — An update

Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 19

Effects of Detergent on α-Synuclein Structure: A Native MS-Ion Mobility Study

Moons, R., Bruijne, R. V. D. W.-D., Maudsley, S. R., Lemière, F., Lambeir, A., & Sobott, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217884 · Cited by 19

Characterization of a Disordered Protein during Micellation: Interactions of α-Synuclein with Sodium Dodecyl Sulfate

Jianhui, T., Sethi, A., Anunciado, D. B., Vu, D. M., & Gnanakaran, S. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp210339f · Cited by 19

Expression Profiling and QTL Analysis: a Powerful Complementary Strategy in Drug Abuse Research

Spence, J., Liang, T., Foroud, T., Lo, D. D., & Carr, L. G. (2004) · Addiction Biology · doi:10.1080/13556210412331308958 · Cited by 19

Molecular Mechanisms of Synaptic Disconnection in Alzheimer’s Disease

Masliah, E., Mallory, M. E., Alford, M. F., DeTeresa, R. M., Iwai, A., & Saitoh, T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60680-9_9 · Cited by 19

Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein

Rodríguez, E. E., Arcos‐López, T., Trujano-Ortiz, L. G., Fernández, C. O., González, F. J., Vela, A., & Quintanar, L. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1376-5 · Cited by 19

Dietary restriction modulates α‐synuclein expression in the aging rat cortex and hippocampus

Mladenović, A., Perović, M., Tanić, N., Petanceska, S. S., Ruždijić, S., & Kanazir, S. (2007) · Synapse · doi:10.1002/syn.20427 · Cited by 19

Alpha-Synuclein Expression in Central Nervous System Tumors Showing Neuronal or Mixed Neuronal/Glial Differentiation

Raghavan, R., White, C. L., Rogers, B. B., Coimbra, C., & Rushing, E. J. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.490 · Cited by 19

The Role of Proteolysis in Amyloidosis

Acquasaliente, L., & Filippis, V. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010699 · Cited by 20

A Novel Tool to Investigate the Early and Late Stages of α-Synuclein Aggregation

Ghosh, S. K., Sakshi, S., Swain, B. C., Chakraborty, R., Tripathy, U., & Chattopadhyay, K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00068 · Cited by 18

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.

Masliah, E., Iwai, A., Mallory, M. E., Uéda, K., & Saitoh, T. (1996) · Europe PMC (PubMed Central) · Cited by 168

Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

Irizarry, M. C., Kim, T., McNamara, M. J., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205

The Non-Amyloid-β Component of Alzheimer’s Disease Plaque Amyloid: Comparative Analysis Suggests a Normal Function as a Synaptic Plasticizer

George, J. M., & Clayton, D. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_16 · Cited by 3

Properties of NACP/α-synuclein and its role in Alzheimer’s disease

Iwai, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00036-3 · Cited by 78

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease

Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51